Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (aml) in community health systems in the united states: a real-world data analysis

Authors

Zartash Gul, Advocate Aurora HealthFollow
Michael A. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Coutinho F, Gul Z, Berry AB, et al. Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (AML) in Community Health Systems in the United States: A real-world data analysis. Blood. 2021;138(Supplement 1):4443-4443. doi:10.1182/blood-2021-148634

Affiliations

Aurora Cancer Care, Advocate Aurora Health

Document Type

Abstract